Pfizer (Germany) Analysis

Pfizer Stock Analysis Notes

About 68.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 1.7. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Pfizer Inc last dividend was issued on the 23rd of January 2026. Pfizer Inc. develops, manufactures, and sells healthcare products worldwide. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York. PFIZER INC operates under Drug Manufacturers - Major classification in Germany and is traded on Frankfurt Stock Exchange. It employs 92400 people. To find out more about Pfizer Inc contact DVM DVM at 212 733 2323 or learn more at https://www.pfizer.com.

Pfizer Inc Investment Alerts

Pfizer Market Capitalization

The company currently falls under 'Mega-Cap' category with a current market capitalization of 133.24 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Pfizer's market, we take the total number of its shares issued and multiply it by Pfizer's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Pfizer Profitablity

The company has Profit Margin (PM) of 0.12 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.25 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.25.

Management Efficiency

Pfizer Inc has return on total asset (ROA) of 0.0519 % which means that it generated a profit of $0.0519 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0858 %, meaning that it generated $0.0858 on every $100 dollars invested by stockholders. Pfizer's management efficiency ratios could be used to measure how well Pfizer manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Pfizer's Return On Tangible Assets are most likely to increase slightly in the upcoming years. The Pfizer's current Return On Capital Employed is estimated to increase to 0.22, while Return On Assets are projected to decrease to 0.04. At this time, Pfizer's Other Current Assets are most likely to increase significantly in the upcoming years. The Pfizer's current Return On Tangible Assets is estimated to increase to 0.10, while Total Current Assets are projected to decrease to roughly 50.2 B.

Technical Drivers

As of the 15th of February 2026, Pfizer holds the Semi Deviation of 1.38, coefficient of variation of 723.8, and Risk Adjusted Performance of 0.1162. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Pfizer, as well as the relationship between them. Please check Pfizer Inc variance, jensen alpha, and the relationship between the standard deviation and information ratio to decide if Pfizer Inc is priced some-what accurately, providing market reflects its current price of 23.44 per share.

Pfizer Inc Price Movement Analysis

Pfizer Outstanding Bonds

Pfizer Predictive Daily Indicators

Pfizer Forecast Models

Pfizer's time-series forecasting models are one of many Pfizer's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Pfizer's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Pfizer Inc Debt to Cash Allocation

Pfizer Inc has accumulated 6.95 B in total debt with debt to equity ratio (D/E) of 78.8, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Pfizer Inc has a current ratio of 1.51, which is within standard range for the sector. Debt can assist Pfizer until it has trouble settling it off, either with new capital or with free cash flow. So, Pfizer's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Pfizer Inc sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Pfizer to invest in growth at high rates of return. When we think about Pfizer's use of debt, we should always consider it together with cash and equity.

Pfizer Total Assets Over Time

Pfizer Assets Financed by Debt

The debt-to-assets ratio shows the degree to which Pfizer uses debt to finance its assets. It includes both long-term and short-term borrowings maturing within one year. It also includes both tangible and intangible assets, such as goodwill.

Pfizer Debt Ratio

16.0

It seems as most of the Pfizer's assets are financed through equity. Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the Pfizer's operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of Pfizer, which in turn will lower the firm's financial flexibility.

Pfizer Corporate Bonds Issued

Pfizer Long Term Debt

Stock analysis is the technique used by a trader or investor to examine and evaluate how Pfizer prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Pfizer shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Pfizer. By using and applying Pfizer Stock analysis, traders can create a robust methodology for identifying Pfizer entry and exit points for their positions.

When running Pfizer's price analysis, check to measure Pfizer's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pfizer is operating at the current time. Most of Pfizer's value examination focuses on studying past and present price action to predict the probability of Pfizer's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pfizer's price. Additionally, you may evaluate how the addition of Pfizer to your portfolios can decrease your overall portfolio volatility.